2020 Q2 Form 10-Q Financial Statement

#000119312520217640 Filed on August 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q2
Revenue $65.04M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $457.0K
YoY Change
% of Gross Profit
Operating Expenses $115.6M
YoY Change
Operating Profit -$50.55M
YoY Change
Interest Expense $40.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$40.00K
YoY Change
Pretax Income -$50.59M
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$50.59M
YoY Change
Net Earnings / Revenue -77.79%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $965.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $306.6K
Receivables
Other Receivables
Total Short-Term Assets $1.272M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $230.6M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.272M
Total Long-Term Assets $230.6M
Total Assets $231.9M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $135.8K
YoY Change
Accrued Expenses $318.7K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $668.5K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $668.5K
Total Long-Term Liabilities
Total Liabilities $8.719M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$140.4K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.000M
YoY Change
Total Liabilities & Shareholders Equity $231.9M
YoY Change

Cashflow Statement

Concept 2020 Q2
OPERATING ACTIVITIES
Net Income -$50.59M
YoY Change
Depreciation, Depletion And Amortization $457.0K
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 dmyt Gain On Marketable Securities Net Dividends And Interest Held In Trust Account
GainOnMarketableSecuritiesNetDividendsAndInterestHeldInTrustAccount
120572
CY2020Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
230640951
CY2019Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
73356
CY2020Q2 us-gaap Cash
Cash
965388
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
306641
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1272029
CY2020Q2 us-gaap Assets
Assets
231912980
CY2019Q4 us-gaap Assets
Assets
73356
CY2020Q2 us-gaap Liabilities
Liabilities
8718536
CY2019Q4 us-gaap Liabilities
Liabilities
49076
CY2020Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
218194440
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
135777
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
33440
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
318749
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15636
CY2020Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
100500
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
113510
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
668536
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49076
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
dmyt Gain On Marketable Securities Net Dividends And Interest Held In Trust Account
GainOnMarketableSecuritiesNetDividendsAndInterestHeldInTrustAccount
641026
us-gaap Operating Income Loss
OperatingIncomeLoss
-667161
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5139676
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24425
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
231912980
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73356
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
446541
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-375969
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
566661
CY2020Q2 us-gaap Franchisor Costs
FranchisorCosts
50000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26135
us-gaap Franchisor Costs
FranchisorCosts
100500
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-496541
CY2020Q2 dmyt Net Income Loss Attributable To Common Class B
NetIncomeLossAttributableToCommonClassB
-447000
dmyt Net Income Loss Attributable To Common Class B
NetIncomeLossAttributableToCommonClassB
-567000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14820
dmyt Underwriting Discount Of Per Unit
UnderwritingDiscountOfPerUnit
0.20
dmyt Business Combination Required Completion Date After Initial Public Offering
BusinessCombinationRequiredCompletionDateAfterInitialPublicOffering
2022-02-25
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
965000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113510
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-390789
us-gaap Net Income Loss
NetIncomeLoss
-139645
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
24280
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140365
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-720
CY2020Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
21819444
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2020Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2019Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
230000000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
13195348
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6600000
CY2020Q1 dmyt Shares Subject To Possible Redemption Amount
SharesSubjectToPossibleRedemptionAmount
218680070
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
251144
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
94843
CY2020Q2 dmyt Shares Subject To Possible Redemption Amount
SharesSubjectToPossibleRedemptionAmount
-485630
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5000004
us-gaap Profit Loss
ProfitLoss
-139645
dmyt Noncash Gain On Marketable Securities Net Dividends And Interest Held In Trust Account
NoncashGainOnMarketableSecuritiesNetDividendsAndInterestHeldInTrustAccount
640951
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
306641
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
129584
dmyt Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
100500
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
113510
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-474894
dmyt Cash Deposited In Trust Account
CashDepositedInTrustAccount
230000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-230000000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24990
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
89844
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
230000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6600000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5094864
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
231440282
dmyt Offering Costs Included In Note Payable
OfferingCostsIncludedInNotePayable
5473
dmyt Noncash Deferred Underwriting Commissions
NoncashDeferredUnderwritingCommissions
8050000
dmyt Shares Subject To Possible Redemption Amount
SharesSubjectToPossibleRedemptionAmount
218194440
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
23000000
CY2020Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2020Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
230000000
CY2020Q1 dmyt Initial Public Offering Costs
InitialPublicOfferingCosts
13200000
CY2020Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
8050000
dmyt Business Combination Required Completion Period After Initial Public Offering
BusinessCombinationRequiredCompletionPeriodAfterInitialPublicOffering
P24M
CY2020Q2 dmyt Working Capital
WorkingCapital
603000
us-gaap Interest Income Operating
InterestIncomeOperating
641000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
25000
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
90000
CY2020Q2 us-gaap Taxes Other
TaxesOther
65000
us-gaap Taxes Other
TaxesOther
2140000
dei City Area Code
CityAreaCode
702
CY2020Q2 dmyt Net Income Loss Attributable To Common Class A
NetIncomeLossAttributableToCommonClassA
56000
dmyt Net Income Loss Attributable To Common Class A
NetIncomeLossAttributableToCommonClassA
427000
dei Entity File Number
EntityFileNumber
001-39232
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-3626708
dei Entity Address Address Line1
EntityAddressAddressLine1
1180 North Town Center Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89144
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
965388
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
965388
CY2020Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
dmyt Business Combination Within In Combination Period Possible Per Share Value Of Residual Assets Remaining Available For Distribution
BusinessCombinationWithinInCombinationPeriodPossiblePerShareValueOfResidualAssetsRemainingAvailableForDistribution
10.00
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Entity Registrant Name
EntityRegistrantName
DMY TECHNOLOGY GROUP, INC.
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001793659
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Local Phone Number
LocalPhoneNumber
781-4313
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At June&#160;30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Making estimates requires management to exercise significant judgment.&#160;It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future conforming events.&#160;Accordingly, the actual results could differ from those estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
dmyt Additional Fee For Deferred Underwriting Commissions Per Unit
AdditionalFeeForDeferredUnderwritingCommissionsPerUnit
0.35
CY2020Q2 dmyt Deferred Underwriter Fee
DeferredUnderwriterFee
8050000
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
4600000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
268749
dmyt Offering Costs Included In Note Payable To Related Party
OfferingCostsIncludedInNotePayableToRelatedParty
64854
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law.
dmyt Class Of Warrant Or Right Exercisable Description
ClassOfWarrantOrRightExercisableDescription
On the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering
dmyt Warrants Expiration Term Description
WarrantsExpirationTermDescription
Five years after the completion of a Business Combination or earlier upon redemption or liquidation
dmyt Warrant Redemption Price Description
WarrantRedemptionPriceDescription
At a price of $0.01 per warrant
dmyt Warrants Expire Date
WarrantsExpireDate
Upon a minimum of 30 days' prior written notice of redemption
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2020Q2 dmyt Cash And Cash Equivalent Held In Trust
CashAndCashEquivalentHeldInTrust
3000
CY2019Q4 dmyt Cash And Cash Equivalent Held In Trust
CashAndCashEquivalentHeldInTrust
0

Files In Submission

Name View Source Status
0001193125-20-217640-index-headers.html Edgar Link pending
0001193125-20-217640-index.html Edgar Link pending
0001193125-20-217640.txt Edgar Link pending
0001193125-20-217640-xbrl.zip Edgar Link pending
d17164d10q.htm Edgar Link pending
d17164dex311.htm Edgar Link pending
d17164dex312.htm Edgar Link pending
d17164dex321.htm Edgar Link pending
d17164dex322.htm Edgar Link pending
dmyt-20200630.xml Edgar Link completed
dmyt-20200630.xsd Edgar Link pending
dmyt-20200630_cal.xml Edgar Link unprocessable
dmyt-20200630_def.xml Edgar Link unprocessable
dmyt-20200630_lab.xml Edgar Link unprocessable
dmyt-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending